Clinical Trial Update: The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Dribbles antigen to activate T cells for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Dribbles Antigen (dribbles antigen)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: UNKNOWN